Jubilant Life To Transfer API, Dosage-Form Business To Singapore Unit
This article was originally published in PharmAsia News
Executive Summary
Jubilant Life Sciences plans to transfer to its Singapore unit the company's active pharmaceutical ingredient and dosage-form business along with its shares in its U.S. unit, Jubilant Pharma Holding USA, and Jubilant Pharma Belgium.